ASND (Ascendis Pharma AS) Shiller PE Ratio: (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASND Ascendis Pharma AS ASND
41 GF Score
Price $270.56
! 3 Warning Signs
View Full Analysis

What is Ascendis Pharma AS Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ascendis Pharma AS  (NAS:ASND) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Ascendis Pharma AS Shiller PE Ratio Related Terms


Ascendis Pharma AS Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Shiller PE Ratio Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ascendis Pharma AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASND vs JAZZ, BBIO, EXEL: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Ascendis Pharma AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma AS Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's Shiller PE Ratio falls into.


ASND
41GF Score
Ascendis Pharma AS ASND
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ascendis Pharma AS's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Ascendis Pharma AS's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.26/122.9700*122.9700
=3.260

Current CPI (Jun. 2026) = 122.9700.

Ascendis Pharma AS Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.808 100.200 -0.992
201612 -0.538 100.300 -0.660
201703 -0.834 101.200 -1.013
201706 -1.056 101.200 -1.283
201709 -1.240 101.800 -1.498
201712 -1.089 101.300 -1.322
201803 -1.319 101.700 -1.595
201806 -0.643 102.300 -0.773
201809 -0.945 102.400 -1.135
201812 -0.865 102.100 -1.042
201903 -1.401 102.900 -1.674
201906 -1.412 102.900 -1.687
201909 -0.584 102.900 -0.698
201912 -1.889 102.900 -2.257
202003 -1.459 103.300 -1.737
202006 -2.218 103.200 -2.643
202009 -2.721 103.500 -3.233
202012 -3.212 103.400 -3.820
202103 -1.393 104.300 -1.642
202106 -3.012 105.000 -3.527
202109 -1.729 105.800 -2.010
202112 -2.113 106.600 -2.437
202203 -2.434 109.900 -2.723
202206 -1.543 113.600 -1.670
202209 -3.000 116.400 -3.169
202212 -3.919 115.900 -4.158
202303 -2.120 117.300 -2.222
202306 -2.340 116.400 -2.472
202309 -3.074 117.400 -3.220
202312 -1.679 116.700 -1.769
202403 -2.500 118.400 -2.596
202406 -2.379 118.500 -2.469
202409 -1.909 118.900 -1.974
202412 -0.670 118.900 -0.693
202503 -1.708 120.200 -1.747
202506 -0.946 120.700 -0.964
202509 -1.174 121.600 -1.187
202512 -0.644 121.200 -0.653
202603 11.272 121.680 11.392
202606 3.260 122.970 3.260

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ascendis Pharma AS Business Description

Other Exchanges A1SN34:Brazil
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
41GF Score

Get the complete analysis for ASND

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$270.56
Price